Intervention

blood tests

ClinicalTrials.gov intervention label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 3 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials3

Recruiting0

Common conditions10

Lead sponsors shown3

Clinical trials

3 shown

SarS-Cov-2 Viral Infection (COVID-19) in Patients With Chronic Inflammatory RheumatismNCT04584541 · 2020-06-11

TERMINATED

Magnetic Resonance Imaging in High Risk Patients for the Development of Diffuse Idiopathic Skeletal Hyperostosis (DISH)NCT03237455 · 2018-08-01

UNKNOWN

Exploration of the Lipid Metabolism During the Diabetic PregnanciesNCT00639964 · 2008-01-01

COMPLETED

Common conditions

Covid191 Diabetes Mellitus1 Hyperostosis, Diffuse Idiopathic Skeletal1 Metabolic Syndrome1 Pregnancy1 Pregnancy in Diabetes1 Rheumatoid Arthritis1 Spondyloarthritis1 Type 1 Diabetes Mellitus1 Type 2 Diabetes Mellitus1

Leading sponsors

Assistance Publique - Hôpitaux de Paris1 HaEmek Medical Center, Israel1 University Hospital, Lille1

Trial status mix

COMPLETED1

TERMINATED1

UNKNOWN1

Phase mix

NA3

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.